Skip to main content

Advertisement

SpringerLink
Log in

Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine

  • Academic Exploration
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

With Chinese medicine (CM) gaining popularity in recent years, researchers and clinicians have put in much interest and effort into the makings and effects of it, especially after the recent announcement of World Health Orgnitation’s incorporation of CM into mainstream medical compendium. Individual herb has complex properties, coming from its pharmacological properties and the Chinese medical principles of organ-directed, taste and dynamic orientational behaviours. The use of individual herb in CM is rare, where various herbs/ingredients are mostly found in a prescribed formula. To fully reveal the effects of CM is a great challenge. The complexity of various herbs in combined effect, the absorption and utility rate by the body, uniqueness of individual physique, sub-types of pathological behaviors and time-line progression of the healing process add on to the complication of understanding the full effect of CM. Various theories such as pathophysiology guidance, pharmacokinetic-pharmacodynamic compatibility method, and Global Systems Biology for Integrative Genomics, Proteomics and Metabolomics, which interactively provide a wider scope, more details, with the consideration of development timeline, may shed more light to revealing the full picture of the effects of compatibility prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217.

    CAS  PubMed  Google Scholar 

  2. Cyranoski D. The big push for Chinese medicine. Nature 2018:448–450.

  3. Deng ZJ, ed. Traditional Chinese medicine Formulary. 3rd ed. Beijing: China Press of Traditional Chinese Medicine; 2012;03:10–13

    Google Scholar 

  4. Chen JP, Wu WK, Zhang MS, Tang TJ, Han F. Study on the ideology and methodology of the compatibility of traditional Chinese medicine compound. Chin J Exp Tradit Med Formul (Chin) 2000;1:1–4.

    Google Scholar 

  5. Deng ZY, Wang MJ, Zhang JQ, Luo GP, Chen Y, Zeng JY, et al. An Cough formulae compatibility qualitative and quantitative research. Shandong J Tradit Chin Med (Chin) 2018;37:456–459, 493.

    Google Scholar 

  6. Mao ZP, Liu HN, Xiong YX, Mo XZ, Qi CC. Data analysis study of usage of formulae compatibility. J Jiangxi Univ Tradit Chin Med (Chin) 2017;29:118–121.

    Google Scholar 

  7. Li Z, Rong YY, Wang SM, Wu CW. Formulae compatibility study. Chin J Exp Tradit Med Formul (Chin) 2015;21:223–226.

    CAS  Google Scholar 

  8. Gao XM, ed. Chinese materia medica. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2002:21–43.

    Google Scholar 

  9. Fan FJ, Hong WX, Song JL, Li SX, Zheng CF. Discovery and research on the formulae visualization compatibility. Chin J Biomed Eng (Chin) 2016;35:764–768.

    Google Scholar 

  10. Fan DM, Huang YQ. Current research on formulae compatibility. Strait Pharm J (Chin) 2018;30:20–23.

    Google Scholar 

  11. Zhang Y, Xie YM. Genetics analysis of Chinese herbal medicine. Chin Arch Tradit Chin Med (Chin) 2001;5:426–427.

    Google Scholar 

  12. Deng ZJ, ed. TCM formulary. 1st ed. Beijing: China Press of Traditional Chinese Medicine; 2003:17–19

    Google Scholar 

  13. Wang XJ. Metabonomics study on Chuan Lian Zi toxicity and compatibility. Hefei: Anhui Medical University, 2011.

    Google Scholar 

  14. Ni JX, Lin YH, Chen MZ. Pharmacokinetics analysis of the compatibility of Zuojin Pill. China Mod Med (Chin) 2011;19:19–20.

    Google Scholar 

  15. Zhong XY, Huo WZ, Gong Q, Peng QT, Zhang XF, Zhu SS. Research status of pharmacokinetics of traditional Chinese medicine compatibility. Chin Herb Med (Chin) 2013;44:3084–3088.

    CAS  Google Scholar 

  16. Wu JF. Formulae compatibility modern scientific research. J Liaoning Coll Tradit Chin Med (Chin) 2014;16:217–219.

    Google Scholar 

  17. Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y. Identification of a new plasma biomarker of Alzheimer’s disease using metabolomics technology. J Lipid Res 2012;53:567–576.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Huang Z, Lin L, Gao Y, Chen Y, Yan X, Xing J, et al. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol Cell Proteom 2011;10:M111.007922–M111.

    Google Scholar 

  19. Roberts MJ, Schirra HJ, Lavin MF, Gardiner RA. Metabolomics: a novel approach to early and noninvasive prostate cancer detection. Ko Urol 2011;52:79–89.

    Google Scholar 

  20. Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R, Manchester M, et al. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 2012;8:232.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Brockmöller SF, Bucher E, Müller BM, Budczies J, Hilvo M, Griffin JL, et al. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer—link to patient survival, hormone receptor status, and metabolic profiling. J Proteome Res 2012;11:850–860.

    PubMed  Google Scholar 

  22. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Ann Rev Pharmacol Toxicol 2008;48:653–683.

    CAS  Google Scholar 

  23. Zhou L, Wang Q, Yin P, Xing W, Wu Z, Chen S, et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem 2012;403:203–213.

    CAS  PubMed  Google Scholar 

  24. Patterson AD, Maurhofer O, Beyoğlu D, Lanz C, Krausz KW, Pabst T, et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 2011;71:6590–6000.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem 2012;58:139–147.

    CAS  PubMed  Google Scholar 

  26. Leslie RD, Beyan H. Metabolomics makes a mark: early changes associated with autoimmune diabetes. Diabetes 2011;60:2688–2690.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Liu CF, Wang N, Liu SM, Huang ZX, Zu JX, Li JH. Metabolomics sudy of Huanglian Jiedu Tang on fever syndrome. J Shandong Univ Tradit Chin Med (Chin) 2011;35:60–63.

    Google Scholar 

  28. Zhao Y, Su W, Zhang QY, Li BT, Xu GL, Liu HN. Effects of Erzhi Pill on urine metabolites in naturally aging mice. Pharmacol Clin Chin Mater Med (Chin) 2011;27:3–5.

    Google Scholar 

  29. Qu HH, Zhao Y, Wang QG. Compound compatibility mechanism based on Chinese medicine moelecular monoclonal antibodies. Chin J Integr Tradit West Med (Chin) 2012;32:1416–1419.

    Google Scholar 

  30. Wang XJ, Zhang BL. Drug metabolomics and scientific compatibility of prescriptions compatibility. China J Chin Mater Med (Chin) 2010;35:1346–1348.

    Google Scholar 

  31. Xu YT. Modern scientific study of formulae compatibility. Chin Herb Med (Chin) 2015;46:465–469.

    CAS  Google Scholar 

  32. Wang ZG, Hu HL, Lan K, Jiang XH. Study on the compatibility of traditional Chinese medicine compounds based on pharmacodynamics-pharmacokinetics method based on metabolomics and prescription theory. Chin Herb Med (Chin) 2009;40:169–172.

    Google Scholar 

  33. Luo GA, Liang QL, Liu QF, Zhang RL, Yang HH, Li X, et al. Integrating chemical systemic study of systemic biology—study on Chinese herbal compatibility and mechanism of Chinese medicine compounds. Modern Tradit Chin Med Mater Med-World Sci Technol (Chin) 2007:10–15, 24.

    Google Scholar 

  34. Hood L, Tian Q. Systems approaches to biology and disease enable translational systems medicine. Genom Proteom Bioinform. 2012;10:181–185.

    CAS  Google Scholar 

  35. Hood L. Systems biology: integrating technology, biology, and computation. Mechan Age Develop 2003;124:9–16.

    Google Scholar 

  36. Nicholson JK, Wilson ID. Understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Disc 2003;2:668.

    CAS  Google Scholar 

  37. Nicholson J. Global systems biology, personalized medicine and molecular epidemiology Mol Syst Biol 2006:52

  38. Li YP, He LS, Zhao Y, Wang L, Cao X, Deng JG. Study status and new thoughts on Chinese materia medica formula used for AIDS treatment. Chin Herb Med (Chin) 2014;45:303–307.

    Google Scholar 

  39. Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, et al. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Integr Cancer Ther 2013;13:152–160.

    PubMed  Google Scholar 

  40. Ren LP, Zhang XQ. Guipi Decoction and Guilu Erxian Decoction on the treatment of breast cancer post chemotherapy myelosuppression 50 cases. Shanxi J Tradit Chin Med (Chin) 2009;30:794–795.

    Google Scholar 

  41. Ma XX, Li YB. Data analysis of treatment of diabetes using Chinese herbal compatibility. West J Tradit Chin Med (Chin) 2015;28:100–103.

    Google Scholar 

  42. Wang CF. Usage and clinical study of Xiaoke Pill treatment on qi-yin deficiency syndrome of type II diabetes. Diabet New World (Chin) 2018;21:73–74.

    Google Scholar 

  43. Zeng ZH, Li HN, Chen GL. Observation on the effect of Xiaoke Pill on qi-yin deficiency syndrome of type 2 diabetes. Diabet New World (Chin) 2013;9:59–60.

    Google Scholar 

  44. Liu Q, Lu C, Zhang WD, Liu RH. Research progress on Shexiang Baoxin Pill. Chin Herb Med (Chin) 2016;47:1409–1417.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NTU Chinese Medicine Clinic, Nanyang Technological University, Singapore, 637551, Singapore

    Loh Cheng Toa Steven & Goh Xin Yi

Authors
  1. Loh Cheng Toa Steven
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Goh Xin Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Loh CT: writing-original draft, review. Goh XY: writing-review, editing. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Goh Xin Yi.

Ethics declarations

All authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steven, L.C.T., Yi, G.X. Discussion on Relevance and Studies of Prescription Compatibility in Chinese Medicine. Chin. J. Integr. Med. 27, 788–793 (2021). https://doi.org/10.1007/s11655-020-3217-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-020-3217-1

Keywords

Search

Navigation